Literature DB >> 30336185

Spiral mouthpiece design in a dry powder inhaler to improve aerosolization.

Hyo-Jung Lee1, In-Ho Kwon2, Hong-Goo Lee1, Yong-Bin Kwon1, Hye-Min Woo1, Sang-Min Cho3, Youn-Woong Choi3, Jinmann Chon4, Kibum Kim5, Dong-Wook Kim6, Chun-Woong Park7.   

Abstract

This study presents the effect of a spiral mouthpiece design in a carrier-based dry powder inhalation on particle aerosol characteristics. Two kinds of mouthpieces, with spiral and non-spiral shaped flow channels, were fabricated by 3D-printing; particle image velocimetry and Anderson cascade impactor were performed to evaluate the drug aerosol characteristics. The obtained experimental results were in agreement with the simulation results of the computational fluid dynamics analysis. The spiral channel created a strong swirl motion of the air flow emitted from the mouthpiece exit, which produced angular momentum rather than the axial flow velocity in the forward direction. This is beneficial in terms of liberating the micronized drug particles from the carrier surface, and leads to more effective delivery of these drug particles to the peripheral target regions of the respiratory system. The spiral device could produce drug particles with significantly smaller mass median aerodynamic diameters and higher fine particle fraction than the non-spiral device.
Copyright © 2018 Elsevier B.V. All rights reserved.

Keywords:  3D-printer; Andersen cascade impactor; Computational fluid dynamics; Dry powder inhaler; Numerical analysis; Particle image velocimetry

Mesh:

Substances:

Year:  2018        PMID: 30336185     DOI: 10.1016/j.ijpharm.2018.10.036

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Effect of inflow conditioning for dry powder inhalers.

Authors:  Gajendra Singh; Albyn Lowe; Athiya Azeem; Shaokoon Cheng; Hak-Kim Chan; Ross Walenga; Agisilaos Kourmatzis
Journal:  Int J Pharm       Date:  2021-09-08       Impact factor: 5.875

Review 2.  In Silico Methods for Development of Generic Drug-Device Combination Orally Inhaled Drug Products.

Authors:  Ross L Walenga; Andrew H Babiskin; Liang Zhao
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.